Multiple Choice
CTL019 was the first gene edited CAR T cell therapy approved by the FDA.Initial treatments of patients with CTL019 demonstrated over _______remission rate after the first treatment.Exemplifying the power of gene editing in treating acute lymphoblastic leukemia.
A) 95%
B) 90%
C) 99%
D) 80%
Correct Answer:

Verified
Correct Answer:
Verified
Q6: What is the target of the first
Q7: Despite the promise of gene therapy treating
Q8: Viral vectors are not the only method
Q9: A patient experiencing a disease state due
Q10: The gene PD- 1 plays an important
Q12: Minimizing off- target effects of gene therapy
Q13: Gene therapy to treat Leber congenital amaurosis
Q14: A serious concern about gene therapies and
Q15: Treatment of ADA- SCID is often considered
Q16: Lentiviral vectors are preferred over adenoviral vectors